![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 1 245021806 1049431875597303 7954320077726829710 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/245021806_1049431875597303_7954320077726829710_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 2 244553696 413518610126159 6980444454992659737 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244553696_413518610126159_6980444454992659737_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 3 244715765 1026329414869084 8253993928057713164 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244715765_1026329414869084_8253993928057713164_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 4 244562284 420994106348992 6130706950121876846 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244562284_420994106348992_6130706950121876846_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 5 244645812 698706048199248 3958864871283146723 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244645812_698706048199248_3958864871283146723_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 6 244653874 395157985444416 2817852025362327867 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244653874_395157985444416_2817852025362327867_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 7 244787164 572740930512859 8662178292419578567 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244787164_572740930512859_8662178292419578567_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 8 244816151 919702292264330 6784380941987715067 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244816151_919702292264330_6784380941987715067_n.jpg)
![OCTs and OCTAs of a Neovascular (wet) Age-Related Macular Degeneration (nARMD) 9 244721083 549222102830473 8054954628305619910 n](https://outlookeye.b-cdn.net/wp-content/uploads/2022/09/244721083_549222102830473_8054954628305619910_n.jpg)
Here’s a series of OCTs and OCTAs of a neovascular (wet) Age-Related Macular Degeneration (nARMD) patient who underwent treatment with intravitreal anti-VEGF injections of Aflibercept.
The initial (2nd image) OCT cross-sectional (B-scan) demonstrates subretinal and intraretinal fluid (SRF & IRF) with subfoveal haemorrhage. The third image is the OCT B-scan with flow overlay showing vascular flow in the subfoveal space. The horizontal lines demonstrate the flow is in the Outer Retina slab. The 4th image is the enface of the deep slab clearly showing the type 2 choroidal neovascular membrane (CNVM). The fourth image is the colour-coded enface angiogram.
The 5th image shows improvement of the CNV on the ORCC and almost complete resorption of the subretinal and intraretinal oedema. This was following their first intravitreal injection. The 6th image shows the corresponding en-face OCTA.
The 7th image demonstrates resolution of the CNV following 3 injections, with all that remains being a fibrous scar. This patient’s vision improved from 6/36 to 6/9 and has remained stable with ongoing treatment.
This series demonstrates both the effectiveness of treatment and utility of OCT Angiography in diagnosing disease and monitoring treatment progression.
#ophthalmology #ophthalmologist #retina #retinopathy #vitreoretinalsurgery #retinasurgery #vitrectomy #eyedisease #eyesurgery #eyedoctor #optometry #optometrist #optometrystudent #macula #maculopathy #laser #medicalretina #medret #medretina #octa #oct #cmo #cme #maculardegeneration #goldcoast #goldcoasteyes #outlookeye #goldcoasteyesurgeon #goldcoastoptom #multimodalimaging